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Apc-mutated Pirc rats, spontaneously developing intestinal tumours, are resistant to 1,2-dimethylhydrazine- (DMH-) induced colon
apoptosis. To understand this phenomenon, we analyzed the expression of genotoxic stress-related genes Mgmt, Gsta1, and Gstp1
in the colon of wt and Pirc rats in basal conditions and 24 h after DMH; plasmatic oxidant/antioxidant status was also evaluated.
After DMH,Mgmt expression was increased in both genotypes but significantly only in wt rats; Gsta1 expression was significantly
increased in both genotypes. Gstp1 expression did not vary after DMH but was lower in Pirc rats. Moreover, for each genotype,
we studied by microarray technique whole gene expression profile after DMH. By unsupervised cluster analysis, 28 genes were
differentially modulated between the two genotypes. Among them were interferon-induced genes Irf7, Oas1a, Oasl2, and Isg15
and the transcription factor Taf6l, overexpressed in DMH-treated wt rats and unchanged in Pirc rats. RT-PCR confirmed their
overexpression in DMH-treated wt rats and showed a slighter variation in DMH-treated Pirc rats. Taken together, despite a blunted
induction of Irf7, Oas1a, and Mgmt, defective apoptosis in Pirc rats 24 h after DMH is not mirrored by major differences in gene
expression compared with wt rats.
1. Introduction
Failure to properly respond to cytotoxic insults (resistance
to apoptosis) has been linked to carcinogenesis in various
organs including colon [1]. During the early phases of
the carcinogenesis process, damaged cells which would be
eliminated by efficient apoptosis may survive and proliferate
into a preneoplastic clone. In the later stages of cancer devel-
opment, an altered apoptotic response may lead to resistance
to cytotoxic chemotherapic drugs. Apc gene, mutated in
Familial Adenomatous Polyposis (FAP) and in themajority of
sporadic colon cancers, has been linked to defective apoptosis
[2], but the mechanisms underlying its involvement in apop-
tosis are not fully understood [3]. Recently [4], we showed
that Pirc rats, mutated in Apc and spontaneously devel-
oping large and small intestinal tumours [5], are resistant
to apoptosis induced by 1,2-dimethylhydrazine (DMH), an
alkylating chemical also inducing oxidative damage [6, 7],
which is widely used to induce colon cancer in rodents
[8]. Indeed, 24 h after DMH treatment, Pirc rats showed
lower apoptosis when compared to wt rats and failed to
stop colon proliferation as wt rats do [4]. To understand the
mechanisms through which Apc gene affects the response to
DMH, we thought it of interest to study in wt and Pirc rats the
expression of some genes involved in repair of DNA damage
and in the detoxification of chemicals, namely, Mgmt (O6-
methylguanine-DNA methyltransferase), Gsta1 (glutathione-
S-transferase-a1), and Gstp1 (glutathione-S-transferase-p1) in
basal conditions and 24 h after DMH. Moreover, to have a
comprehensive view of the responses induced by DMH and
not only those foreseen in advance, we also studied at whole
genomic level the transcription profile after DMH in the two
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genotypes. In addition, since the ability to respond to DMH
may be due, at least in part, to the antioxidant activity present
in the plasma, we also measured the antioxidant potential in
the plasma of these animals.
2. Materials and Methods
2.1. Animals and Treatments. Pirc (F344/NTac-Apcam1137)
and wild type (wt) Fisher F344/NTac rats were originally
obtained by Taconic (Taconic Farms, Inc., USA) and bred
in CESAL (University of Florence, Italy) in accordance with
the Commission for Animal Experimentation of the Italian
Ministry of Health. The Pirc colony was maintained by
mating heterozygous Pirc rats with wt and pups genotyped at
one month of age [4]. Rats were maintained in polyethylene
cages under an experimental protocol approved by the Com-
mission for Animal Experimentation of the Italian Ministry
of Health.
2.2. Experimental Design. Male rats of 2 months of age
(both genotypes) were randomly allocated to 1,2-dimeth-
ylhydrazine (DMH) treatment (75mg/kg; s.c.) (DMH-treated
rats) or saline (rats in basal conditions) and sacrificed 24 h
later as described [4]. The total number of animals used for
the experiments was 12, 17, 10, and 14 for wt rats in basal con-
ditions, DMH-treated wt rats, Pirc rats in basal conditions,
and DMH-treated Pirc rats, respectively. To minimize the
number of animals, we used, when possible, the same animal
for different determinations.
At sacrifice, blood was collected for the determination
in the plasma of ferric reducing ability of plasma (FRAP) as
previously described [4]. The entire colon (from cecum to
anus) was dissected and flushed with cold saline. Apparently,
morphological normal mucosa (NM) was scraped and stored
in RNA-later (Qiagen) at −80∘C until RNA extraction,
carried out by using NucleoSpin RNA (Macherey-Nagel)
according to manufacturer’s instructions.
2.3. Semiquantitative RT-PCR. Gene expression was evalu-
ated in the colonic NM. Pirc and wt rats were analyzed
with procedures previously described [9]. The primers used
for the amplification of the different genes were the fol-
lowing: Gsta1 (also known as Gsta3, NM 031509): Fw (5󸀠-
3󸀠) GGACAAAGCAAGGAACCGTT, Rv (5󸀠-3󸀠) CAG-
AGGGAAGTTGGCCAAAG; Gstp1 (NM 012577): Fw (5󸀠-
3󸀠) TACTTCATCGTCCACGCAGC, Rv (5󸀠-3󸀠) GGACTT-
GAGCGAGCCTTGAA; Irf7 (NM 001033691): Fw (5󸀠-3󸀠)
CCTCTGCTTTCTGGTGATGC, Rv (5󸀠-3󸀠) GCGCTC-
AGTCATCAGAACTG; Mgmt (NM 012861): Fw (5󸀠-3󸀠)
GCCTATTTCCACGAACCTGC, Rv (5󸀠-3󸀠) CCTCAT-
CGCTCCTCCTACTG; Oas1a (NM 138913): Fw (5󸀠-3󸀠)
CTGAAGAGTCTCATCCGCCT, Rv (5󸀠-3󸀠) CCCTGA-
GCTGTGTTGAACTC; Oasl2 (NM 001009682): Fw (5󸀠-
3󸀠) GTGAAAAGTCGCCCGGTTAA, Rv (5󸀠-3󸀠) CTG-
TACCCATCTCCCAAGCA; Taf6l (NM 001107575) Fw (5󸀠-
3󸀠) AGGACTTCAACAGGGCTCTC, Rv (5󸀠-3󸀠) AGACAT-
GAACTCTGACGGCT; Isg15 (NM 001106700) Fw (5󸀠-3󸀠)
ATCCTCTGAGCATCCTGGTG, Rv (5󸀠-3󸀠) GTGGGGT-
GTTAGGCCATACT; Rplp1 (NM 001007604): Fw (5󸀠-3󸀠)
TGCTCTCATTAAAGCAGCTGG, Rv (5󸀠-3󸀠) AAAGAC-
CAAAGCCCATGTCA. For each gene, the relative amount
of mRNA in the samples was calculated as the ratio of each
gene to the ribosomal housekeeping gene Rplp1mRNA.
2.4. Statistical Analysis. Data for each group (wt rats in basal
conditions, DMH-treated wt rats, Pirc rats in basal condi-
tions, and DMH-treated Pirc rats) were expressed as mean
percentage (+SE) of the wt rats in basal conditions. To take
into account the effect of both genotype andDMH treatment,
values were subjected to two-way ANOVA. Analyses were
performed with the software GraphPad Prism version 5.02.
Within each genotype, differences between DMH-treated
animals and basal conditions were also evaluated by t-test,
as post hoc analysis. Differences were considered significant
when 𝑃 was ≤0.05.
2.5. Microarray Experiments. For gene expression analysis,
total RNA was extracted from samples of colon mucosa
harvested from 6 DMH-treated wt rats and 8 wt rats in
basal conditions, 4 DMH-treated Pirc rats, and 5 Pirc rats
in basal conditions. For each genotype, the labeling and
hybridization steps were carried out according to the Agilent
protocol (Two-Color Microarray-Based Gene Expression
Analysis version 5.7), using a two-color microarray protocol
in which DMH-treated samples were contrasted within each
genotype with a reference RNA obtained by pooling equal
amount of RNA from colon mucosa samples harvested from
rats in basal conditions. In the case of wt rats, 6 DMH-
treated rats were individually contrasted with a pool from
8 wt rats in basal conditions; in the case of Pirc rats, a
pool from 4 DMH-treated rats was contrasted with a pool
from 5 Pirc rats in basal conditions performing two technical
replicas. The labeled samples were hybridized to Agilent Rat
GE 8x60K Oligo 60-mer microarrays, in Agilent microarray
chambers (G2534A) at 65∘C for 18 h. After hybridization, the
microarray slides were washed by using the Agilent Gene
Expression Wash Buffers. Fluorescent signal intensities were
detected by using the Agilent Scan Control 7.0 software
on an Agilent microarray scanner, at a resolution of 2 𝜇m.
Image analysis and initial quality control were performed
using Agilent Feature Extraction software v9.5. Values for
control spots and spots that did not meet the quality criteria
were flagged. Quality criteria included a minimal spot size, a
median/mean ratio of at least 0.9 for each spot, nonsaturated
intensity for both channels, a signal well above background,
and a minimal signal intensity for at least one channel. In wt
rats, differences in gene expression between DMH treatment
and basal conditions were analyzed by t-test, comparing
normalized red (DMH-induced samples) versus green (basal
conditions) signals and applying a cut-off of fold change
≥3. In the case of Pirc rats, since the data came from
a pool of samples, t-test analysis was not performed and
we only applied a cut-off of fold change ≥3. The pairwise
average-linkage cluster analysis was applied to differentially
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Figure 1: Ratio of Mgmt, Gsta1, and Gstp1 ((a), (b), and (c), resp.)/to the ribosomal housekeeping gene Rplp1 mRNA in wt rats in basal
conditions, DMH-treated wt rats, Pirc rats in basal conditions, and DMH-treated Pirc rats. Values are expressed as percent over the basal wt
mean values. (d) FRAP determination in wt, DMH-treated wt, Pirc, and DMH-treated Pirc rats. # and §: significant effect of DMH treatment
or genotype, respectively, by two-way ANOVA analysis. ∗: significantly different compared to the corresponding basal condition by t-test
analysis (𝑃 < 0.05).
expressed genes using the Cluster 3.0 and Treeview software,
a method of unsupervised hierarchical clustering in which
relationships among genes and samples are represented by
trees whose branch lengths reflect the degree of similarity
between genes and samples [10]. The microarray data sets
supporting the results of this article are available in the
MIAME public database ArrayExpress repository [http://
www.ebi.ac.uk/arrayexpress/] (accession number: E-MTAB-
4910).
3. Results
3.1. Expression of Genes Involved in DMH Response. We first
studied, by RT-PCR, the expression of Mgmt, involved in
the response to DMH [11]. Since in the experimental scheme
adopted both genotypes were present in basal conditions and
after treatment with DMH, data (Figure 1(a)) were analyzed
with two-way ANOVA to highlight, if any, an effect of the
genotype irrespective of DMH or of DMH treatment irre-
spective of genotype. The results showed significant upreg-
ulation ofMgmt expression in the colon mucosa after DMH,
while the effect of genotype (wt or Pirc) was not significant
(Figure 1(a)). Considering separately each genotype, we noted
that Mgmt expression was significantly higher in DMH-
treated wt rats compared with their basal values (t-test),
while considering Pirc rats DMH effect was not significant.
Regarding Gsta1 (Figure 1(b)), it was upregulated in DMH-
treated rats of both genotypes, while Gstp1 (Figure 1(c))
expression was not varied by DMH but a significant effect
of the genotype was present, with Pirc rats showing a lower
expression of this gene compared with wt rats.
We also measured FRAP in the plasma of the rats in the
four experimental groups (Figure 1(d)). Two-way ANOVA
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Figure 2: Unsupervised hierarchical cluster analysis based on the 101 genes significantly changed in the wt strain (𝑃 < 0.05) after DMH and
with FC ≥ 3 by microarray technique. Genes are listed in rows. In columns, the individual expressions of 6 DMH-treated wt rats (numeric
code) or 2 pooled Pirc RNA are reported. Cluster 1 comprises 21 genes that were overexpressed in wt rats but not changed in Pirc rats; cluster
2 comprises 7 genes that, after DMH treatment, were downregulated in wt rats and overexpressed in Pirc rats. Note that the unsupervised
analysis was able to separate Pirc from wt rats (columns).
showed a significant effect of DMH treatment and a signif-
icant interaction between strain and treatment. Considering
the data for each genotype, DMH-treated Pirc rats showed a
higher level of FRAP compared with their basal values, while
the DMH effect in wt rats was not significant.
3.2. Microarray Experiments. To have a more comprehensive
view of the differences between the two genotypes in response
to DMH, we evaluated by whole genome array analysis
DMH-related changes in the gene expression of colonmucosa
comparing six wt rats exposed to DMH (24 h before) with a
pool of eight wt rats in basal conditions. The results of this
analysis showed that in DMH-treated rats 3173 genes were
differentially expressed (𝑃 < 0.05) compared with rats in
basal conditions: 1536 of them were upregulated and 1637
were downregulated. Using an arbitrary cut-off of 3 as fold
change (FC) versus baseline, we found 101 genes differentially
expressed after DMH (61 upregulated and 40 downregulated)
(Supplementary Table 1 in Supplementary Material available
online at http://dx.doi.org/10.1155/2016/1310342).
As a second step, we analyzed the expression profile of
Pirc rats after treatment with DMH, comparing the expres-
sion profile of a pool of colonic samples from 5 rats exposed
to DMH (24 h before) with a pool of 4 samples from Pirc rats
in basal conditions. In this case, having only two technical
replicas, we applied the arbitrary fold change cut-off of 3 as in
wt rats, but t-test was not performed. This analysis identified
223 genes upregulated and 209 genes downregulated byDMH
in Pirc rats (Supplementary Table 2).
To highlight differences between the two genotypes, we
then performed an unsupervised cluster analysis of the array
data relative to the 101 genes significantly changed in wt
rats (Supplementary Table 1). With this analysis, relation-
ships among genes and samples are represented by trees
whose branch lengths reflect the degree of similarity between
the variables (Figure 2). Regarding the similarities among
samples, the analysis identified two main clusters composed
of Pirc and wt rats, respectively (Figure 2). Regarding the
similarities among genes, the analysis identified two main
clusters composed of genes predominantly upregulated or
predominantly downregulated, respectively. Within the clus-
ter of the predominantly upregulated genes, we noticed a
group of closely related genes, cluster 1, composed by 21 genes
which were overexpressed in wt rats but not changed in Pirc
rats. Within the cluster of the predominantly downregulated
genes, we identified a group of genes with similar expression
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patterns, cluster 2, containing 7 genes which, after DMH
treatment, were downregulated in wt rats and overexpressed
in Pirc rats (Figure 2).
Within cluster 1, we noticed some genes controlled by
interferon (IFN) such as Irf7 (interferon regulatory factor
7), Oas1a (2󸀠-5󸀠-oligoadenylate synthetase 1A), Oasl2 (2󸀠-5󸀠-
oligoadenylate synthetase-like 2), and Isg15 (ISG15 ubiquitin-
like modifier) as well as the transcription factor Taf6l
(TAF6-like RNA polymerase II, p300/CBP-associated factor
(PCAF)) which, after DMH, were overexpressed in wt rats
but not changed in Pirc rats. For these genes, we verified the
results obtained with the arrays with RT-PCR. Regarding Irf7
gene (Figure 3(a)), RT-PCR experiments confirmed signifi-
cant upregulation in DMH-treated wt rats when compared
with their basal counterpart, while in Pirc rats, the slight
upregulation inDMH-treated ratswas not significant. Similar
upregulation in DMH-treated wt rats was observed forOas1a
(Figure 3(b)), with a borderline effect (𝑃 = 0.08) forTaf6l gene
(Figure 3(c)), while the variation in DMH-treated Pirc rats
was not significant. RegardingOasl2 gene (Figure 3(d)), it was
upregulated in DMH-treated wt rats but, at variance with the
data in the array experiment, was significantly upregulated
also in DMH-treated Pirc rats. For Isg15 gene (Figure 3(e)),
only a slight increase in the expression was observed in
both wt rats and Pirc rats treated with DMH. The two-way
ANOVAof the results shown in Figure 3 showed a statistically
significant effect of the DMH treatment (irrespective of the
genotype) for Irf7, Oas1a, and Oasl2 genes and borderline
effect of DMH for Taf6l and Isg15 genes (𝑃 = 0.06 and
0.07, resp.). For Isg15 gene, a significantly different expression
between the two genotypes was also observed.
4. Discussion
DMH (1,2-dimethylhydrazine) is a procarcinogen which is
metabolized into methylazoxymethanol (MAM) and in turn
to a highly reactive electrophile (methyl diazonium ion),
which not only alkylates DNA but also causes oxidative stress
[6, 7, 12–14]. This chemical is widely used not only to induce
colon carcinogenesis in rodents [8] but also to study the
early response to carcinogens in the colon [15, 16]. Using
the latter experimental scheme, we recently showed that Pirc
rats, mutated in Apc gene, were resistant to DMH-induced
apoptosis when compared to wt rats [4].
Aiming at identifying genes whose differential expression
in wt andApc-mutated rats might explain the defective apop-
tosis in Pirc rats; we studiedMgmt, involved in the response to
alkylating agents, as well as Gsta1 and Gstp1, involved in the
defence against xenobiotic/carcinogens [11, 17]. MGMT is a
key enzyme in the repair ofDNAdamage by alkylating agents,
acting with a suicidal mechanism [11]. Although Kerr and
colleagues [16] showed downregulation of Mgmt expression
in rat colon 6 h after azoxymethane (AOM), a metabolite
of DMH acting on DNA with the same mechanism, several
studies documented that Mgmt is upregulated by exposure
to alkylating agents [11, 18]. Previous studies in rats also
demonstrated that, shortly after AOM treatment, MGMT
enzymatic activity is depleted and remains undetectable for
two days [19]. Here we showed upregulation of Mgmt 24 h
after DMH in wt rats. Given the suicidal mechanism of
action of MGMT, our result is compatible with Nyskohus’s
findings [19] and suggests that the overexpression of the gene
is due to a compensatory feedback mechanism. Although in
DMH-treated Pirc rats the overexpression of Mgmt is not
significant compared to that observed in DMH-treated wt
rats, we document that the effect of DMHwas present in both
wt and Pirc rats, suggesting that the upregulation ofMgmt is
a mechanism in common between the two genotypes.
GSTA1 and GSTP1 are members of the GST (glutathi-
one S-transferase) superfamily of enzymes catalyzing the
glutathione-dependent detoxification of electrophilic xenobi-
otics and certain products of oxidative stress [20]. Increased
expression of GST isoforms has been associated with the
beneficial effects of various dietary compounds in vivo [17,
21]. We found that in both genotypes Gsta1 was significantly
overexpressed inDMH-treated rats, indicating in both strains
that this gene is inducible by DMH. At variance with Gsta1,
Gstp1 expression was not changed in both wt and Pirc rats
after DMH; however, a significant effect of the genotype was
observed, indicating that Pirc rats have a lower expression
of this gene. It is interesting to note that Min mice mutated
in Apc and null for Gstp gene showed enhanced intestinal
carcinogenesis [22], suggesting a protective role for this gene.
Therefore, it would be possible to speculate that the lower
expression of Gstp1 in Pirc rats could contribute to their
spontaneous carcinogenesis as well as to their increased
susceptibility to the carcinogenic effect of ethylnitrosourea
[5], an alkylating agent which may also indirectly cause
oxidative damage [23].
We previously showed that Pirc rats have a lower level
of FRAP in the plasma when compared to wt rats [4].
Since this parameter may reflect the ability of plasma to
counteract the toxic effect of oxidant xenobiotics, we thought
that it was interesting to study its levels after DMH. Two-
way ANOVA showed a significant effect of DMH in both
genotypes; however, the analysis also highlighted a significant
interaction between the two variables (genotype and DMH
treatment) suggesting a different pattern of response to DMH
in the two genotypes, which deserves further investigation.
To have a more comprehensive view of the responses to
DMH beyond those predictable, we also performed whole
genome expression profile analysis by using DNAmicroarray
technology. Although previous studies evaluated variations
in gene expression profile in cancer cells and animals in
response to toxic treatments [15, 24], the response to geno-
toxic stress at whole gene level in animals mutated in Apc has
not been studied so far.
The results of the unsupervised cluster analysis carried
out on genes differentially affected in wt after DMH (fold
change ≥ 3, 𝑃 < 0.05) identified two clusters composed by
genes that were overexpressed in wt rats but not changed
in Pirc rats (21 genes) or downregulated in wt rats and
overexpressed in Pirc rats (7 genes). Among these genes we
noticed that some are regulated by IFN, namely, Irf7, Oas1a,
Oasl2, and Isg15. Irf7 is a member of the IFN regulatory
factors (IRF), involved in defensive responses not only against
viral infections but also against DNA-damaging chemicals
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Figure 3: Ratio of selected genes/to the ribosomal housekeeping gene Rplp1mRNA in wt rats in basal conditions, DMH-treated wt rats, Pirc
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BioMed Research International 7
[25, 26]. Accordingly, several chemotherapic drugs such
as Adriamycin, Mitomycin, and Cisplatin activate Irf7 in
cancer cell lines [25]. Oas1a and Oasl2 belong to the 2󸀠-
5󸀠-oligoadenylate synthetase (OAS) family also induced by
IFN and associated with antiviral and apoptotic response
[26]. OAS genes have been also associated with response
to cytotoxic chemicals such as cyclophosphamide [27] and
to radiations [24]. In agreement with these reports, we also
found, at least in wt rats, upregulation of these genes after
treatment with DMH. Verifying the array data with RT-PCR
experiments, we found slight upregulation of these genes in
DMH-treated Pirc rats. Analyzing data by two-way ANOVA,
no significant differences between the two genotypes were
found but only an effect of DMH, as also observed forMgmt
expression. The only exception was Isg15, a cytokine also
induced by IFN [28], whose expression in both genotypes
was not significantly varied afterDMH, but two-wayANOVA
analysis was shown to be significantly expressed at lower
levels in Pirc rats.
In conclusion, the resistance to DMH-induced apoptosis
in Pirc rats [4] is not mirrored by major differences at
the whole genome level. However, a blunted induction of
interferon-related genes (Irf7 andOas1a) andMgmt, involved
in the response to DMH, was observed. These changes,
together with other minor differences, could explain the
altered apoptotic response in Pirc rats.
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